Probiotic pathogen inhibition composition and method
AssigneeMicrobios, Inc.
InventorsMatthew Ryan GARNER, Joseph F. Flint
Life of this patent
Estimating the term…
Abstract
A bacterial composition and method that inhibits E. coli O157:H7 growth by as much as 93% and Salmonella growth by as much as 97%, together with commensurate inhibition rates against the Big-Six Escherichia coli strains referred to as the non-O157 STECs that include E. coli O121:H19; E. coli O45:H2; E. coli O103:H11; E. coli O145, E. coli O26:H11; and E. coli O111. The composition is constituted of various combinations of the following unique pathogen-inhibiting bacteria: (1) Lactobacillus animalis; (2) Enterococcus faecium (3) Pediococcus acidilactici.
Claims20
A probiotic composition comprising a number of viable Lactobacillus animalis bacteria wherein the composition has an E. coli O157:H7 growth inhibition rate of at least 50% when mixed with an equal number of viable E. coli O157:H7 bacteria.
A probiotic composition comprising a number of viable Enterococcus faecium bacteria wherein the composition has an E. coli O157:H7 growth inhibition rate of at least 80% when mixed with an equal number of viable E. coli O157:H7 bacteria.
A probiotic composition comprising a number of viable Pediococcus acidilactici bacteria wherein the composition has an E. coli O157:H7 growth inhibition rate of at least 80% when mixed with an equal number of viable E. coli O157:H7 bacteria.
Dependencies are inferred from the claim text.